Kytopen: Funding, Investors & Team (Oct 2026)
Kytopen develops a cell therapy platform that allows for the non-viral delivery of molecules into immune cells that are typically difficult to manipulate. By utilizing microfluidics and automation, their technology streamlines the process of delivering molecules without the need for viruses, making it more accessible and cost-effective for researchers to develop innovative biological discoveries for cell and gene therapies.
Kytopen has raised $3.6M across 3 funding rounds on record, the most recent a Series B announced in Apr 2026.
Kytopen Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Kytopen Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Kytopen raised $2.0M in an undisclosed round announced in Jun 2021.
3.2 years later, an undisclosed round of $1.6M was announced in Aug 2024.
1.7 years later, a Series B was announced in Apr 2026 with no disclosed amount.
Kytopen Founders and Leadership Team
Contact details for the Kytopen team: 2 of 3 have an email address on file.
Start 14-day free trial →Kytopen Funding Compared to Other Biotechnology Startups
Funded Startups Like Kytopen in Biotechnology and Cambridge
Companies Similar to Kytopen
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Kytopen Funding FAQs
What does Kytopen do?
Kytopen develops a cell therapy platform that allows for the non-viral delivery of molecules into immune cells that are typically difficult to manipulate. By utilizing microfluidics and automation, their technology streamlines the process of delivering molecules without the need for viruses, making it more accessible and cost-effective for researchers to develop innovative biological discoveries for cell and gene therapies.
How much funding has Kytopen raised?
Kytopen has raised $3.6M across 3 rounds on record.
When did Kytopen last raise funding?
Kytopen's most recent funding round on record was announced in Apr 2026. The amount was not disclosed.
Who founded Kytopen?
FundedIQ lists Michael Chiu (Founder), Paulo Garcia (Founder) at Kytopen.
Who is the CEO of Kytopen?
Paulo A. Garcia is listed as CEO at Kytopen.
Where is Kytopen headquartered?
Kytopen is based in Cambridge, Massachusetts, United States.
How many employees does Kytopen have?
Kytopen is in the 11-50 employee band.
About FundedIQ's Kytopen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kytopen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.